Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.3 (
glutathione synthetase
)
678
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pyroglutamic aciduria (5-oxoprolinuria) is a rare autosomal recessive disorder caused by either
glutathione synthetase
deficiency (GSSD) or 5-oxoprolinase deficiency. GSSD results in low glutathione levels in erythrocytes and may present with hemolytic anemia alone or together with pyroglutamic aciduria, metabolic acidosis, and CNS damage. Five patients with pyroglutamic aciduria were studied. All presented with hemolytic anemia and metabolic acidosis. Two (brothers) also had Fanconi
nephropathy
, which is not seen in pyroglutamic aciduria. Molecular analyses of the
GSS
gene was performed in 3 patients. RT-PCR and heteroduplex analysis identified a homozygous deletion in 1 patient and a homozygous mutation in 2 others (brothers with Fanconi
nephropathy
). Sequencing of
glutathione synthetase
(
GSS
) cDNA from the first patient showed a 141-bp deletion corresponding to the entire exon 4, whilst the corresponding genomic DNA showed a G491 --> A homozygous splice site mutation. Sequencing of
GSS
cDNA from the Fanconi
nephropathy
patients showed a C847 --> T [ARG283 --> CYS] mutation in exon 9.
...
PMID:Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency. 1045 Aug 61